BMS partnership with Volastra $30 mill upfront and $1 billion in...

BMS partnership with Volastra
$30 mill upfront and $1 billion in milestones/royalties

Immutep much further advanced but BP preference is low upfront $$ (risk) and back end loaded - which could be many years based on product sales %age.

Some long term IMM shareholders on this forum have this preference too. Built on an assumption of multiple licensing deals with BP in various cancer indications, which in theory reap ongoing dividends to SH's.

Personally. I'm in the camp of maximum return based on highest probability of success and shortest time frame

Time to enjoy the spoils of over a decade of contributing to capital raises and being disappointing 'false dawns'.

Also I cannot see several BP's sharing efti for the betterment of humankind. It's a tough business.

We are dancing with big players but imo only one will take us home to meet the parents before tying the knot.

I could be well wrong of course. But we are getting close to the nexus point. Great imminent TACTI data my we'll be the catalyst for BP to make a move????